Survey of fertility preservation options available to patients with cancer around the globe

• Autor(a) principal: Alexandra S. Rashedi
• Data de Publicação: 2017
• Outros Autores: Bruno Ramalho de Carvalho, Cassio Sartorio, Catharina C.M. Beerendonk, Cesar Diaz Garcia, Chang Suk Suh, Claudia Melo, Claus Yding Andersen, Eduardo Motta, Ellen M. Greenblatt, Ellen Van Moer, Saskia F. de Roo, Elnaz Zand, Fernando Marcos Dos Reis, Flor Sanchez, Guillermo Terrado, Jhenifer K. Rodrigues, João Marcos de Meneses e Silva, Johan Smitz, Jose Medrano, Jung Ryeol Lee, Katharina Winkler Crepaz, Lauren Ataman, Kristin Smith, Ligia Helena Ferreira Melo e Silva, Ludwig Wildt, Mahmoud Salama, María del Mar Andrés, Maria T. Bourlon, Mario Vega, Mauricio Barbour Chehin, Michel de Vos, Mohamed Khrouf, Maxwell E. Edmonds, Nao Suzuki, Osama Azmy, Paula Fontoura, Paulo Henrique Almeida Campos Junior, Peter Mallmann, Ricardo Azambuja, Ricardo M. Marinho, Richard A. Anderson, Robert Jach, Roberto de Antunes, Adelino Amaral Silva, Rod Mitchell, Rouhollah Fathi, Satish Kumar Adiga, Seido Takae, Seok Hyun Kim, Sergio Romero, Silvana Chedid Grieco, Talya Shaulov, Tatsuro Furui, Teresa Almeida Santos, Anibal Scarella, Willianne Nelen, Yasmin Jayasinghe, Yodo Sugishita, Teresa K. Woodruff, Anna Horbaczewska, Antoinette Anazodo, Ayse Arvas
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da UFMG
• Texto Completo: http://hdl.handle.net/1843/59208; https://orcid.org/0000-0002-3186-6451; https://orcid.org/0000-0001-7921-1633; https://orcid.org/0000-0003-3179-3763; https://orcid.org/0000-0002-2773-1343; https://orcid.org/0000-0003-1835-7350; https://orcid.org/0000-0001-7681-253X; https://orcid.org/0000-0003-1556-7184; https://orcid.org/0000-0001-5108-8776; https://orcid.org/0000-0002-8393-986X; https://orcid.org/0000-0001-6584-3429; https://orcid.org/0000-0002-4517-0420; https://orcid.org/0000-0002-5857-6542; https://orcid.org/0000-0002-7616-1375; https://orcid.org/0000-0003-3743-2934; https://orcid.org/0000-0002-7684-9778; https://orcid.org/0000-0003-4979-4684; https://orcid.org/0000-0002-3883-7821; https://orcid.org/0000-0003-1933-2593; https://orcid.org/0000-0002-0282-8018; https://orcid.org/0000-0002-3116-912X; https://orcid.org/0000-0001-8589-6448; https://orcid.org/0000-0001-5019-5924; https://orcid.org/0000-0002-8698-0171; https://orcid.org/0000-0003-4226-1818; https://orcid.org/0000-0002-7483-736X; https://orcid.org/0000-0003-0448-4842; https://orcid.org/0000-0003-2400-2548; https://orcid.org/0000-0001-5612-9733; https://orcid.org/0000-0003-0777-559X; https://orcid.org/0000-0003-3871-5207; https://orcid.org/0000-0002-2897-4697; https://orcid.org/0000-0002-0783-0758; https://orcid.org/0000-0002-6598-0762; https://orcid.org/0000-0002-2581-0128; https://orcid.org/0000-0003-4855-219X; https://orcid.org/0000-0001-7423-2996; https://orcid.org/0000-0002-3905-321X; https://orcid.org/0000-0003-2438-2261; https://orcid.org/0000-0001-5975-9378; https://orcid.org/0000-0003-4315-1370; https://orcid.org/0000-0002-1197-3399; https://orcid.org/0000-0003-1094-5377; https://orcid.org/0000-0002-5495-6062; https://orcid.org/0000-0002-9474-8858
• topic: Oncofertility; Cancer; Cancer; Oncologia

PURPOSE Oncofertility focuses on providing fertility and endocrine-sparing options to patients who undergo lifepreserving but gonadotoxic cancer treatment. The resources needed to meet patient demand often are fragmented along disciplinary lines. We quantify assets and gaps in oncofertility care on a global scale. METHODS Survey-based questionnaires were provided to 191 members of the Oncofertility Consortium Global Partners Network, a National Institutes of Health–funded organization. Responses were analyzed to measure trendsand regional subtleties about patient oncofertility experiences and toanalyze barriers to care at sites that provide oncofertility services. RESULTS Sixty-three responses were received (response rate, 25%), and 40 were analyzed from oncofertility centers in 28 countries. Thirty of 40 survey results (75%) showed that formal referral processes and psychological care are provided to patients at the majority of sites. Fourteen of 23 respondents (61%) stated that some fertility preservation services are not offered because of cultural and legal barriers. The growth of oncofertility and its capacity to improve the lives of cancer survivors around the globe relies on concentrated efforts to increase awareness, promote collaboration, share best practices, and advocate for research funding. CONCLUSIONThissurveyrevealsglobalandregionalsuccessesandchallengesandprovidesinsightintowhatis needed to advance the field and make the discussion of fertility preservation and endocrine health a standard component of the cancer treatment plan. As the field of oncofertility continues to develop around the globe, regular assessment of both international and regional barriers to quality care must continue to guide process improvements.